PPAR Receptor Agonist
Active Substance: Cardarine
Manufacturer: Dragon Pharma
Unit: 100 pills (20 mg/pill)
Laboratory Tested: 2024-06-18
Cadarine
GW501516, produced by Dragon Pharma, is an oral compound containing the active substance Cardarine. It is a Peroxisome Proliferator-Activated Receptor delta (PPARδ) agonist.
1 pill contains:
Active substance: Cardarine 20 mg
GW501516 is renowned in the bodybuilding community for its ability to enhance endurance, promote fat loss, and improve cardiovascular health without impacting muscle mass.
While not prescribed for therapeutic purposes, GW501516 has shown promise in research for potential applications in improving lipid metabolism and combating obesity.
Typical dosages for men range from 10 to 20 mg per day. The cycle duration can vary, but it is often used for 8-12 weeks.
For women, a lower dosage in the range of 5 to 10 mg per day is generally recommended to minimize the risk of virilization.
GW501516 has a relatively long half-life, allowing for once-daily dosing.
While generally well-tolerated, potential side effects may include headaches and mild gastrointestinal discomfort. However, no significant adverse effects have been reported in studies.
Individuals with pre-existing medical conditions, especially related to the cardiovascular system, should exercise caution. Pregnant or breastfeeding women should avoid its use. Consultation with a healthcare professional before use is advisable.
There is limited information on the effects of overdosage with GW501516. As with any compound, exceeding recommended doses may increase the risk of adverse effects.
GW501516 is often used in cutting cycles to enhance fat loss and improve endurance. It can be stacked with other performance-enhancing compounds, but it is crucial to consult with a healthcare professional for personalized advice. An example cycle might include 10-20 mg of GW501516 daily, alongside a calorie-controlled diet and regular exercise.
GW501516 is presented in sachets, each containing 100 tablets of 20 mg Cardarine.
Store GW501516 in a cool, dry place, away from direct sunlight. Follow the storage instructions provided by the manufacturer and keep it out of reach of children.
Aromatase Inhibitor for Post Cycle Therapy
Active Substance: Anastrozole
Manufacturer: Dragon Pharma
Unit: 100 pills (1 mg/pill)
Laboratory Tested: 2024-06-17
Aromatase Inhibitor for Post Cycle Therapy
Active Substance: Exemestane
Manufacturer: Dragon Pharma
Unit: 100 pills (25 mg/pill)
Laboratory Tested: 2017-01-25
Selective Estrogen Receptor Modulator for Post Cycle Therapy
Active Substance: Clomiphene Citrate
Manufacturer: Dragon Pharma
Unit: 100 pills (50 mg/pill)
Aromatase Inhibitor for Post Cycle Therapy
Active Substance: Letrozole
Manufacturer: Dragon Pharma
Unit: 100 pills (2.5 mg/pill)
Laboratory Tested: 2017-01-31
Selective Estrogen Receptor Modulator for Post Cycle Therapy
Active Substance: Tamoxifen Citrate
Manufacturer: Dragon Pharma
Unit: 100 pills (20 mg/pill)
Laboratory Tested: 2024-08-26
Selective Androgen Receptor Modulator
Active Substance: Ligandrol
Manufacturer: Dragon Pharma
Unit: 100 pills (15 mg/pill)
Laboratory Tested: 2023-09-22
Selective Estrogen Receptor Modulator
Active Substance: Toremifene Citrate
Manufacturer: Dragon Pharma
Unit: 100 pills (20 mg/pill)